Categories
Change Password!
Reset Password!
Tapinarof 1% shows strong safety profile in psoria...
Tapinarof 1% offers clinically meaningful relief i...
Tapinarof 1% cream administered once per day remarkably improves disease severity and pruritus in atopic dermatitis (AD), according to the outcom...
Cetirizine among top performers for nasal symptoms...
A large network meta-analysis explored the efficacy and safety of oral H1-antihistamines in allergic rhinitis (AR) by synthesizing evidence from...
Budesonide nasal spray improves symptom control in...
Chronic idiopathic urticaria (CIU), a distressing condition marked by persistent hives, intense itching, and episodic angioedema lasting longer t...
Respiratory allergy testing: A comparative review...
Accurate identification of allergen sensitization plays a crucial role in the management of asthma and allergic rhinitis (AR), with diagnostic ap...
Network meta-analysis identifies INAH+INCS as top-...
A major systematic review and network meta-analysis of 167 trials has clarified the comparative safety and efficiency of intranasal antihistamine...
OM-85 shows immunomodulatory benefits in children...
Allergic rhinitis (AR) is a common chronic ailment in children that markedly affects daily activities, emotional wellbeing, and overall quality o...
Sexual health severely impacted in patients with g...
Psoriatic disease affecting the genital region (GenPsO) and other areas of sexual interest (ASI) remains a clinically sensitive yet underrecogniz...
Canadian experts update guidance on allergic rhini...
A newly released Canadian-focused practice parameter is reshaping the clinical approach to allergic rhinitis (AR), emphasizing individualized tre...
New international urticaria guideline advances bio...
A major international update to urticaria care is providing clinicians with more detailed recommendations on disease classification, diagnostic w...
